167 related articles for article (PubMed ID: 19647859)
21. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
[TBL] [Abstract][Full Text] [Related]
22. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.
Trimble CL; Morrow MP; Kraynyak KA; Shen X; Dallas M; Yan J; Edwards L; Parker RL; Denny L; Giffear M; Brown AS; Marcozzi-Pierce K; Shah D; Slager AM; Sylvester AJ; Khan A; Broderick KE; Juba RJ; Herring TA; Boyer J; Lee J; Sardesai NY; Weiner DB; Bagarazzi ML
Lancet; 2015 Nov; 386(10008):2078-2088. PubMed ID: 26386540
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients.
Deutsch E; Haie-Meder C; Bayar MA; Mondini M; Laporte M; Mazeron R; Adam J; Varga A; Vassal G; Magné N; Chargari C; Lanoy E; Pautier P; Levy A; Soria JC
Oncotarget; 2016 May; 7(18):25549-57. PubMed ID: 27016411
[TBL] [Abstract][Full Text] [Related]
24. Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia.
Huang HJ; Tung HJ; Yang LY; Chao A; Tang YH; Chou HH; Chang WY; Wu RC; Huang CC; Lin CY; Liao MJ; Chen WC; Lin CT; Chen MY; Huang KG; Wang CJ; Chang TC; Lai CH
Int J Cancer; 2021 Feb; 148(3):665-672. PubMed ID: 32781482
[TBL] [Abstract][Full Text] [Related]
25. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus infection in patients with residual or recurrent cervical intraepithelial neoplasia.
Takac I
Tumori; 2008; 94(1):83-6. PubMed ID: 18468341
[TBL] [Abstract][Full Text] [Related]
27. The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up.
Harper DM; Nieminen P; Donders G; Einstein MH; Garcia F; Huh WK; Stoler MH; Glavini K; Attley G; Limacher JM; Bastien B; Calleja E
Gynecol Oncol; 2019 Jun; 153(3):521-529. PubMed ID: 30955915
[TBL] [Abstract][Full Text] [Related]
28. Predictors of absence of cervical intraepithelial neoplasia in the conization specimen.
Rodriguez-Manfredi A; Alonso I; del Pino M; Fusté P; Torné A; Ordi J
Gynecol Oncol; 2013 Feb; 128(2):271-6. PubMed ID: 23116936
[TBL] [Abstract][Full Text] [Related]
29. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.
Park JY; Lee SM; Yoo CW; Kang S; Park SY; Seo SS
Gynecol Oncol; 2007 Oct; 107(1):39-44. PubMed ID: 17582476
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus 16 and 18 infection of the uterine cervix in women with different grades of cervical intraepithelial neoplasia (CIN).
Takac I; Marin J; Gorisek B
Int J Gynaecol Obstet; 1998 Jun; 61(3):269-73. PubMed ID: 9688488
[TBL] [Abstract][Full Text] [Related]
31. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-analysis.
Lichter K; Krause D; Xu J; Tsai SHL; Hage C; Weston E; Eke A; Levinson K
Obstet Gynecol; 2020 May; 135(5):1070-1083. PubMed ID: 32282601
[TBL] [Abstract][Full Text] [Related]
33. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
Niu XY; Feng YK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy for management of cervical intraepithelial neoplasia II and III in young patients and obstetric outcomes.
Choi MC; Jung SG; Park H; Lee SY; Lee C; Hwang YY; Kim SJ
Lasers Surg Med; 2013 Nov; 45(9):564-72. PubMed ID: 24136239
[TBL] [Abstract][Full Text] [Related]
35. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
Nagai Y; Maehama T; Asato T; Kanazawa K
Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
[TBL] [Abstract][Full Text] [Related]
36. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
38. p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome.
Branca M; Ciotti M; Santini D; Di Bonito L; Giorgi C; Benedetto A; Paba P; Favalli C; Costa S; Agarossi A; Alderisio M; Syrjänen K
Int J Gynecol Pathol; 2004 Oct; 23(4):354-65. PubMed ID: 15381905
[TBL] [Abstract][Full Text] [Related]
39. The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins.
Song SH; Park HM; Eom DW; Lee JK; Lee NW; Kim AR; Hur JY; Lee KW; Park YK; Saw HS
Int J Gynecol Cancer; 2007; 17(4):858-67. PubMed ID: 17367326
[TBL] [Abstract][Full Text] [Related]
40. Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III.
Ruffin MT; Bailey JM; Normolle DP; Michael CW; Bieniasz ME; Kmak DC; Unger ER; Brenner DE
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2148-52. PubMed ID: 15598773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
